Raymond D. Blind

1.6k total citations
33 papers, 1.2k citations indexed

About

Raymond D. Blind is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Raymond D. Blind has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Genetics and 6 papers in Oncology. Recurrent topics in Raymond D. Blind's work include Estrogen and related hormone effects (10 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Raymond D. Blind is often cited by papers focused on Estrogen and related hormone effects (10 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Raymond D. Blind collaborates with scholars based in United States, Australia and Germany. Raymond D. Blind's co-authors include Michael J. Garabedian, Holly A. Ingraham, Miyuki Suzawa, Claudio N. Cavasotto, Zhen Wang, Adam B. Hittelman, Susan K. Logan, Inez Rogatsky, Weiwei Chen and Robert J. Fletterick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Raymond D. Blind

30 papers receiving 1.2k citations

Peers

Raymond D. Blind

GENET

EDM

ONCOL

Anne Guiochon‐Mantel France

Anne‐Marie Lefrançois‐Martinez France

P E Schwartz United States

Joshua O. Scheys United States

Emily R. Weikum United States

Angel Matías Sanchez Italy

Guillermo P. Vicent Spain

Marina Inés Flamini Argentina

Catharine L. Smith United States

Deanna R. Brickley United States

Anne Guiochon‐Mantel France

Raymond D. Blind

753 ×1.1

660 ×1.5

GENET

286 ×1.4

EDM

169 ×0.8

ONCOL

87 ×0.5

Citations per year, relative to Raymond D. Blind Raymond D. Blind (= 1×) peers Anne Guiochon‐Mantel

Countries citing papers authored by Raymond D. Blind

Since Specialization

Citations

This map shows the geographic impact of Raymond D. Blind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond D. Blind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond D. Blind more than expected).

Fields of papers citing papers by Raymond D. Blind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond D. Blind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond D. Blind. The network helps show where Raymond D. Blind may publish in the future.

Co-authorship network of co-authors of Raymond D. Blind

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond D. Blind. A scholar is included among the top collaborators of Raymond D. Blind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond D. Blind. Raymond D. Blind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yubai, Desmarini Desmarini, Michael A. Stashko, et al.. (2025). Design, Synthesis, and Cellular Characterization of a New Class of IPMK Kinase Inhibitors. Journal of Medicinal Chemistry. 68(15). 15446–15460. 1 indexed citations

Wang, Huanchen, Stephen B. Shears, & Raymond D. Blind. (2025). Structural Rationalization of IPMK Inhibitor Potency. Journal of Medicinal Chemistry. 68(22). 24316–24325.

Palamiuc, Lavinia, Jared L. Johnson, Archna Ravi, et al.. (2024). Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP. Science Signaling. 17(838). eado6266–eado6266. 5 indexed citations

Blind, Raymond D., et al.. (2024). A novel heuristic of rigid docking scores positively correlates with full-length nuclear receptor LRH-1 regulation. Computational and Structural Biotechnology Journal. 23. 3065–3080.

Rameh, Lucia E., et al.. (2024). Inositol phosphates dynamically enhance stability, solubility, and catalytic activity of mTOR. Journal of Biological Chemistry. 301(2). 108095–108095.

Oeser, James K., Kwang-Ho Kim, Derek P. Claxton, et al.. (2024). Biochemical and metabolic characterization of a G6PC2 inhibitor. Biochimie. 222. 109–122. 2 indexed citations

Blind, Raymond D., et al.. (2023). Steroidogenic Factor-1 form and function: From phospholipids to physiology. Advances in Biological Regulation. 91. 100991–100991. 2 indexed citations

Blind, Raymond D., et al.. (2023). SF-1 Induces Nuclear PIP2. Biomolecules. 13(10). 1509–1509. 3 indexed citations

Rameh, Lucia E. & Raymond D. Blind. (2023). 25 Years of PI5P. Frontiers in Cell and Developmental Biology. 11. 1272911–1272911. 6 indexed citations

10.

Malabanan, M. Merced, et al.. (2021). The acyl chains of phosphoinositide PIP3 alter the structure and function of nuclear receptor steroidogenic factor-1. Journal of Lipid Research. 62. 100081–100081. 12 indexed citations

11.

Kuenze, Georg, et al.. (2020). Integrated Structural Modeling of Full-Length LRH-1 Reveals Inter-domain Interactions Contribute to Receptor Structure and Function. Structure. 28(7). 830–846.e9. 22 indexed citations

12.

Haliyur, Rachana, Xin Tong, May Sanyoura, et al.. (2018). Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks. Journal of Clinical Investigation. 129(1). 246–251. 60 indexed citations

13.

Blind, Raymond D., et al.. (2018). Signaling through non-membrane nuclear phosphoinositide binding proteins in human health and disease. Journal of Lipid Research. 60(2). 299–311. 23 indexed citations

14.

Blind, Raymond D., et al.. (2016). Phospholipid regulation of the nuclear receptor superfamily. Advances in Biological Regulation. 63. 6–14. 34 indexed citations

15.

Blind, Raymond D.. (2013). Disentangling biological signaling networks by dynamic coupling of signaling lipids to modifying enzymes. Advances in Biological Regulation. 54. 25–38. 22 indexed citations

16.

Blind, Raymond D., Inès Pineda‐Torra, Yong Xu, H. Eric Xu, & Michael J. Garabedian. (2012). Ligand structural motifs can decouple glucocorticoid receptor transcriptional activation from target promoter occupancy. Biochemical and Biophysical Research Communications. 420(4). 839–844. 8 indexed citations

17.

Mullaney, Brendan, Raymond D. Blind, George A. Lemieux, et al.. (2010). Regulation of C. elegans Fat Uptake and Storage by Acyl-CoA Synthase-3 Is Dependent on NR5A Family Nuclear Hormone Receptor nhr-25. Cell Metabolism. 12(4). 398–410. 54 indexed citations

18.

Lin, Benjamin C., Miyuki Suzawa, Raymond D. Blind, et al.. (2009). Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation. Cancer Research. 69(13). 5415–5423. 135 indexed citations

19.

Hickson, Gilles R.X., Stephanie Taché, Raymond D. Blind, et al.. (2008). Applying innovative educational principles when classes grow and resources are limited. Biochemistry and Molecular Biology Education. 36(6). 387–394. 5 indexed citations

20.

Ismaı̈li, Naı̈ma, Raymond D. Blind, & Michael J. Garabedian. (2005). Stabilization of the Unliganded Glucocorticoid Receptor by TSG101. Journal of Biological Chemistry. 280(12). 11120–11126. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact